Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Late-onset multiple sclerosis in South-East wales.
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis - insights into possible drug mechanism.
Bladder management in multiple sclerosis.
Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation.
The pathological and physiological roles of IL-6 amplifier activation.
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
Molecular mechanisms of scar-sourced axon growth inhibitors.
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.
Endocannabinoids and the Immune System in Health and Disease.
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Autoimmune thyroiditis associated with neuromyelitis optica (NMO).
Remyelination Therapy in Multiple Sclerosis.
Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
[Microglia in neuroimmunological disorders].
RNA processing-associated molecular mechanisms of neurodegenerative diseases.
Including a subject-paced trial may make the PASAT more acceptable for MS patients.
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data.
Lipid Resonance on In Vivo Proton MR Spectroscopy: Value of Other Metabolites in Differential Diagnosis.
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
Pages
« first
‹ previous
…
596
597
598
599
600
601
602
603
604
…
next ›
last »